learn Baricitinib JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases
research Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review 14 citations , April 2023 in “Acta Dermato Venereologica” Upadacitinib effectively treated severe hair loss in a child.
research Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report 12 citations , July 2023 in “Journal of the European Academy of Dermatology and Venereology” Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.
research Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report 10 citations , January 2023 in “SAGE Open Medical Case Reports” Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.
research Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata 9 citations , January 2023 in “Dermatology and therapy” A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.
research Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-centre retrospective study 7 citations , August 2024 in “Clinical and Experimental Dermatology” Upadacitinib is effective and safe for treating severe alopecia areata in teens.